Breaking News Instant updates and real-time market news.

SHOO

Steven Madden

$37.15

0.65 (1.78%)

07:07
04/21/17
04/21
07:07
04/21/17
07:07

Steven Madden CEO says Q1 was 'strong' start to 2017

Edward Rosenfeld, Chairman and CEO, commented, "We are pleased to have started off 2017 with a strong first quarter. The highlight was our Steve Madden Women's wholesale footwear division, where we had another quarter of outstanding growth in a challenging retail environment. Steve and his design team have created an exceptional product assortment that is enabling us to outperform the competition and take market share with our flagship brand. As we look ahead to the balance of the year, we are taking a prudent approach to planning our business in light of retail industry headwinds. That said, the strength in our core business gives us confidence that we are well-positioned to navigate the uncertain environment."

  • 21

    Apr

  • 26

    May

SHOO Steven Madden
$37.15

0.65 (1.78%)

02/24/17
ADAM
02/24/17
NO CHANGE
Target $45
ADAM
Buy
Steven Madden price target raised to $45 from $40 at Canaccord
Canaccord analyst Camilo Lyon raised his price target on Steven Madden to $45 from $40 following meetings with management. The analyst sees multiple trends spurring a strong spring season and sees the company as the only one in the firm's coverage that can continue to thrive in the challenged retail landscape because its supply model is geared to respond in near-real time to changing consumer tastes. Lyon reiterated his Buy rating on Steven Madden shares.
02/27/17
RILY
02/27/17
UPGRADE
Target $45
RILY
Buy
Steven Madden upgraded to Buy from Neutral at B. Riley
B. Riley analyst Jeff Van Sinderen upgraded Steven Madden to Buy and raised his price target for the shares to $45 from $40. Last week's footwear show and latest channel checks underscore the company's potential for growth, Van Sinderen tells investors in a research note.
02/27/17
02/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) upgraded to Buy from Neutral at B. Riley by analyst Jeff Van Sinderen, who said last week's footwear show and latest channel checks underscore the company's potential for growth. 2. Illumina (ILMN) upgraded to Buy from Hold at Evercore ISI by analyst Ross Muken following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. 3. Carnival (CCL) upgraded Buy from Hold by Argus analyst John Staszak, who now believes that "continued " improvement in demand for cruises will improve the company's earnings and margins. 4. Cempra (CEMP) upgraded to Buy at Roth Capital by analyst Michael Higgins after the company announced positive Phase 3 results in the first of two skin infection studies with Taksta, and ahead of bone data in 2017. The analyst also raised his price target on the shares to $8 from $2.50. 5. Unilever (UN) upgraded to Neutral from Underperform at BofA Merrill Lynch by analyst David Hayes, citing valuation and his belief that the strategic review could accelerate margin development targets over the next 4 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/17
SBSH
03/07/17
NO CHANGE
SBSH
Steven Madden added to "Value Creators" SMID Focus List at Citi
Citi analyst Scott Chronert added Steven Madden (SHOO) to his firm's "Value Creators" SMID Focus List while removing Berry Plastics (BERY). Steven Madden is well positioning for current footwear fashion trends, Chronert tells investors in a research note.

TODAY'S FREE FLY STORIES

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

DMPI

DelMar Pharmaceuticals

$1.12

0.0294 (2.70%)

15:33
09/20/17
09/20
15:33
09/20/17
15:33
Syndicate
DelMar Pharmaceuticals announces $10M registered direct offering at-the-market »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$47.94

0.27 (0.57%)

15:30
09/20/17
09/20
15:30
09/20/17
15:30
Options
Far downside put buying in Morgan Stanley »

Far downside put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 22

    Oct

JWN

Nordstrom

$46.13

-0.09 (-0.19%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Conference/Events
Nordstrom management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$71.38

-1.1 (-1.52%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Options
Bunge call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:25
09/20/17
09/20
15:25
09/20/17
15:25
General news
More from Yellen on inflation »

More from Yellen on…

WFC

Wells Fargo

$53.95

0.591 (1.11%)

15:22
09/20/17
09/20
15:22
09/20/17
15:22
Hot Stocks
Chair Yellen calls Wells Fargo actions 'unacceptable' »

Fed Chair Janet Yellen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 12

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

15:20
09/20/17
09/20
15:20
09/20/17
15:20
General news
The FOMC dot-plot projections »

The FOMC dot-plot…

$NSD

NASDAQ Market Internals

15:17
09/20/17
09/20
15:17
09/20/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

$NYE

NYSE Market Internals

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$170.00

4.17 (2.51%)

15:14
09/20/17
09/20
15:14
09/20/17
15:14
Conference/Events
Lennox management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

VXX

iPath S&P 500 VIX Short-Term Futures

$41.28

0.37 (0.90%)

15:10
09/20/17
09/20
15:10
09/20/17
15:10
Options
Notable put write in longer-term options on the Short-term VIX ETN »

Notable put write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:09
09/20/17
09/20
15:09
09/20/17
15:09
General news
Yellen repeats intention to serve out term as chair »

Fed Chair Yellen added…

DLPH

Delphi

$100.88

-0.02 (-0.02%)

, BBRY

BlackBerry

$9.14

-0.12 (-1.30%)

15:05
09/20/17
09/20
15:05
09/20/17
15:05
Hot Stocks
Delphi confirms autonomous driving partnership agreement with BlackBerry »

Delphi Automotive (DLPH)…

DLPH

Delphi

$100.88

-0.02 (-0.02%)

BBRY

BlackBerry

$9.14

-0.12 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UAA

Under Armour

$16.43

-0.38 (-2.26%)

15:00
09/20/17
09/20
15:00
09/20/17
15:00
Options
Under Armour attracts a bullish option play as the slide in shares continues »

Under Armour attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

14:55
09/20/17
09/20
14:55
09/20/17
14:55
General news
Fed Chair Yellen reiterated the FOMC statement »

Fed Chair Yellen…

MLHR

Herman Miller

$34.95

0.1 (0.29%)

14:49
09/20/17
09/20
14:49
09/20/17
14:49
Options
Herman Miller options imply 9.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SPX

S&P 500

14:47
09/20/17
09/20
14:47
09/20/17
14:47
General news
Yellen says Fed has commitment to raising inflation to 2% »

Federal Reserve Chair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHD

Church & Dwight

$49.66

-0.91 (-1.80%)

14:47
09/20/17
09/20
14:47
09/20/17
14:47
Syndicate
Breaking Syndicate news story on Church & Dwight »

Church & Dwight files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 07

    Nov

CSBR

Champions Oncology

$3.38

-0.21 (-5.85%)

14:45
09/20/17
09/20
14:45
09/20/17
14:45
Hot Stocks
Champions Oncology receives $2M contract from HHS contract 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$66.58

0.64 (0.97%)

, FIS

FIS

$92.36

-0.41 (-0.44%)

14:45
09/20/17
09/20
14:45
09/20/17
14:45
Recommendations
TSYS, FIS analyst commentary  »

TSYS, FIS combination…

TSS

TSYS

$66.58

0.64 (0.97%)

FIS

FIS

$92.36

-0.41 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.